Arcutis BiotherapeuticsÂ Inc (ARQT) Financials

$24.39

$0.49 (2.05%)

As on 08-Sep-2026 16:00EDT

Market cap

$3,004 Mln

Revenue (TTM)

$464 Mln

P/E Ratio

108.6

P/B Ratio

13.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	463.98	376.07	196.54	59.61	3.69	--
Cost of Revenue	41.10	36.70	19.13	4.99	0.75	0.76
Gross Profit	422.89	339.38	177.41	54.62	2.93	-0.76
Operating Expenses	388.63	351.60	305.81	295.72	304.56	206.53
Operating Profit (EBIT)	34.25	-12.23	-128.40	-241.10	-301.63	-206.53
Other Income	--	--	--	--	--	0.17
Profit before Tax	29.30	-14.97	-139.39	-259.03	-311.46	-206.36
Provision for Tax	0.78	1.17	0.65	3.11	9.83	-0.45
Profit after Tax (Net Income)	28.52	-16.14	-140.04	-262.14	-311.46	-205.90
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-311.46	-206.36

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	220.58	189.48	157.54	88.67	209.58	297.68
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	107.62	113.66	110.34	206.03	201.89	77.15
Current Liabilities	160.34	129.84	81.01	46.67	37.81	33.33
Total Liabilities	648.88	432.97	348.89	341.37	449.27	408.15

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	20.87	21.74	13.07	10.93	11.87	5.38
Current Assets	467.67	411.23	335.82	330.43	437.41	402.77
Total Assets	648.88	432.97	348.89	341.37	449.27	408.15
Total Debt*	114.14	6.27	110.59	205.92	202.54	77.56
Net Current Assets	307.33	281.39	254.81	283.76	399.60	369.45

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-5.63	-112.16	-247.06	-257.72	-174.63
Cash Flow from Investing Activities	--	-30.25	28.82	180.23	-87.20	-75.95
Cash from Financing Activities	--	6.97	66.20	101.32	301.80	281.95
Net Cash Inflow / Outflow	--	--	--	--	--	31.37

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.21	-0.12	-1.16	-2.83	-5.11	-4.10
Cash EPS ($)	--	-0.08	-1.14	-2.82	-5.09	-4.09
Adjusted Book Value ($)	--	1.40	1.30	0.96	3.44	5.93
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.04	-0.93	-2.67	-4.23	-3.48
Free Cash Flow per Share ($)	--	-0.05	-0.93	-2.67	-4.61	-3.50

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-6.96	-49.77	-74.19	-79.11	-63.27
ROE (%)	13.91	-9.30	-113.76	-175.79	-122.80	-72.46
ROA (%)	5.16	-4.13	-40.58	-66.31	-72.65	-58.29
EBIT Margin (%)	8.88	-0.77	-57.10	-384.72	-8,025.12	--
Net Margin (%)	6.15	-4.29	-71.25	-439.79	-8,449.76	-119,018.50
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	76.11	0.91	2.30	15.17	--	--
EBIT Growth (%)	155.56	97.43	51.06	22.48	-43.23	-52.22
Net Profit Growth (%)	130.58	88.47	46.58	15.83	-51.27	-51.76
EPS Growth (%)	127.72	0.90	0.59	0.45	-0.25	-0.30
Book Value Growth (%)	48.32	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	108.64	-244.03	-12.03	-1.14	-2.90	-5.06
Price / Book Value	13.48	20.79	10.70	3.37	4.30	3.50
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	62.77	1,501.66	-14.30	-1.02	-2.36	-3.54
Close Price ($)	26.22	29.04	13.93	3.23	14.80	20.74
High Price ($)	31.77	31.77	15.79	17.57	27.40	38.49
Low Price ($)	13.06	11.13	3.07	1.76	13.37	14.16
Market Cap ($ Cr)	3,004.04	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.46	0.03	0.70	2.32	0.97	0.26
Short term debt to equity ratio	0.03	0.01	0.01	0.01	0.00	0.00
Current Ratio	2.92	3.17	4.15	7.08	11.57	12.09
Quick Ratio	2.67	2.99	3.97	6.80	11.37	12.05
Interest Coverage	3.12	-0.24	-4.13	-7.72	-18.90	-454.91

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	33.44	38.88	37.18	43.30	229.46	--
Asset Turnover	0.84	0.96	0.57	0.15	0.01	--
Receivable days	--	106.49	91.87	104.98	436.99	--
Inventory Days	--	184.94	264.08	756.13	2,105.76	160.37
Payable days	--	133.12	250.26	762.40	3,918.93	3,468.92
Cash Conversion Cycle	--	158.31	105.70	98.72	-1,376.18	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.